Table of Contents
- Tables of classes of recommendations and levels of evidence
- What is new in the 2019 Guidelines?
- Epidemiology and natural history
- Predisposing factors
- Pathophysiology and determinants of outcome
- Diagnosis
- Clinical presentation
- Assessment of clinical (pre-test) probability
- D-dimer testing
- Imaging tests for diagnosis of pulmonary embolism
- Echocardiography
- Compression venous ultrasonography
- Recommendations for diagnosis
- Assessment of pulmonary embolism severity and the risk of early death
- Recommendations for prognostic assessment....
- Treatment in the acute phase
- Haemodynamic and respiratory support
- Initial anticoagulation
- Reperfusion treatment
- Multidisciplinary pulmonary embolism teams
- Vena cava filters
- Recommendations for acute-phase treatment of high-risk PE
- Recommendations for acute-phase treatment of intermediate or
low-risk PE - Recommendations for multidisciplinary pulmonary embolism teams
- Recommendations for inferior vena cava filters
- Recommendations for early discharge and home treatment
- Integrated risk-adapted diagnosis and management
- Diagnostic strategies
- Treatment strategies
- Chronic treatment and prevention of recurrence
- Assessment of venous thromboembolism recurrence risk
- Anticoagulant-related bleeding risk
- Recommendations for the regimen and duration of anticoagulation
after PE in patients without cancer
- Recommendations for the regimen and duration of anticoagulation
- Management of pulmonary embolism in patients with cancer
- Recommendations for the regimen and the duration of anticoagulation after PE in patients with active cancer
- Pulmonary embolism and pregnancy
- Diagnosis of pulmonary embolism in pregnancy
- Treatment of pulmonary embolism in pregnancy
- Recommendations for pulmonary embolism in pregnancy
- Long-term sequelae of pulmonary embolism
- Persisting symptoms and functional limitation
- Chronic thromboembolic pulmonary hypertension
- Strategies for patient follow-up after pulmonary embolism
- Recommendations for follow-up after acute PE